(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in the Prefilled Syringes Market include rapid growth driven by GLP-1 obesity therapeutics and rising self-injection demand, preference for ...

China’s state-backed investors are stepping up funding for artificial intelligence-driven drug developers as Beijing pushes for technological self-reliance, with at least one company already advancing ...

The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...

Researchers engineer CAR-astrocytes to target and remove amyloid plaques in Alzheimer’s, showing a 50% reduction in brain ...

New hypertension treatments may reduce dosage to two injections annually instead of daily pills Zilebesiran uses siRNA to lower blood pressure by targeting angiotensinogen production in the liver Long ...

Lev Facher covers the U.S. addiction and overdose crisis. ROCHESTER, N.H. — Megan Merrill paused, mid-hike, as she surveyed the steep drop before her. She was standing on a five-foot snow drift, icy ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...

Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade “I just felt slow: I want to be able to do anything my kids want to do and not have weight ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Mari Uyehara and Samantha Schoech There are plenty of good reasons to get ...

About 36% of individuals who are on Novo Nordisk's (NVO) Wegovy (semaglutide) pill, which hit the market in January, are new to GLP-1s, a new study found. Healthcare research firm Truveta said that ...

A wave of government-linked investment is boosting Chinese AI drug makers, underscoring Beijing's drive to build its own biotech ecosystem China's state-backed investors are stepping up funding for ...